Actively Recruiting
Gut Microbiome in Inflammatory Bowel Disease
Led by Kyunghee University Medical Center · Updated on 2023-03-10
1500
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity. In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large academic referral IBD center. Using an integrated multi-omics bioinformatic analysis, the investigators aim to explore gut microbial signatures along with distinct clinical/genetic features, and their potential interplay in patients with IBD.
CONDITIONS
Official Title
Gut Microbiome in Inflammatory Bowel Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease
You will not qualify if you...
- History of using antibiotics or probiotics within the previous 2 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kyung Hee University Hospital
Seoul, South Korea, 130-702
Actively Recruiting
Research Team
C
Chang Kyun Lee, M.D.,Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here